Detection of viable myocardium: Comparison of dobutamine echocardiography and echocardiography after hyperbaric oxygenation

Undersea and Hyperbaric Medicine

Volumn 26, Issue 1, 1999, Pages 9-13

  Veselka, J ^a   Mates, M ^a   Dolezal V ^a  

^a NONE

Author keywords

Dobutamine stress echocardiography; Hyperbaric oxygenation; Left ventricular dysfunction; Myocardial viability

Indexed keywords

CARDIOTONIC AGENT; DIAGNOSTIC AGENT; DOBUTAMINE;

ARTICLE; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; EXERCISE TEST; FEMALE; HEART CONTRACTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERBARIC OXYGEN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY;

CARDIOTONIC AGENTS; DOBUTAMINE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; HYPERBARIC OXYGENATION; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033094349     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Aschermann M. Hibernujíci myokard. Cor Vasa 1995; 37:209-11.
2. Gould KL. Myocardial viability. What does it mean and how to measure it? Circulation 1991; 83:333-335.
3. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993; 87:1-20.
4. Bonow RO. Identification of viable myocardium. Circulation 1996; 94:2674-2680.
5. Ackerman NB, Brinkley FB. Oxygen tensions in normal and ischemic tissues during hyperbaric therapy. JAMA 1966; 198: 1280-1310.
6. Grim PS, Gottlieb LJ, Boddie A, Baston E. Hyperbaric oxygen therapy. JAMA 1990; 263:2216-2220.
7. Swift PC, Turner JH, Oxer HF, O'Shea JP, Lane GK, Woollard KV. Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. Am Heart J 1992; 124: 1151-1158.
8. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiol 1989; 2:358-2367.
9. Sawada SG, Segar DS, Ryan T, et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83:1605-1614.
10. Thomas MP, Brown LA, Sponseller DR, Williamson SE, Diaz JA, Guyton DP. Myocardial infarct size reduction by the synergistic effect of hyperbaric oxygen and recombinant tissue plasminogen activator. Am Heart J 1990; 120:771-778.
11. Kawamura M, Sakakibara K, Sakakibara B. Protective effect of hyperbaric oxygen for temporary ischemic myocardium. Macroscopic and histologic data. Cardiovasc Res 1976; 10:599-604.
12. hiderov VM, Zakharov VN, Askenova TN. Use of hyperbaric oxygenation for treating arrhythmias. Klin Med 1982; 60:51-55.
13. Thurston JGB, Greenwood TW, Bending MR, Connor H, Curwen MP. A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Q J Med 1973; 168:751-770.
14. Eroshina VA, Gasilin VS, Goliakov VN, Vakhlakov AN. Effect of hyperbaric oxygen on the indicators of the functional status of the myocardium in patients with ischemie heart disease. Kardiologija 1986; 26:61-65.
15. Efuni SN, Kudriashov VE, Rodionov VV, Beletski IV, Telegin IN. Value of the isometric exercise test in objectively evaluating the effectiveness of hyperbaric oxygenation in ischemic heart disease. Kardiologija 1984; 24:77-80.
16. Basset BE, Bennett PB. Introduction to the physical and physiological bases of hyperbaric therapy. In: Davis JC, Hunt TK, eds. Hyperbaric oxygen therapy. Bethesda: Undersea Medical Society, 1977:11-24.
17. Jain KK. Hyperbaric oxygen therapy in cardiovascular disease. In: Jain KK, ed. Textbook of hyperbaric medicine. Toronto: Hogrefe & Huber, 1990:283-307.
18. Baer FM, Voth E, Deutsch HJ, et al. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 1996; 28:60-69.
19. Baer FM, Voth E, LaRosée K, et al. Comparison of dobutamine echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. Am J Cardiol 1996; 78:415-419.
20. Afridi I, Main ML, Grayburn PA. Accuracy of dobutamine echocardiography for detection of myocardial viability in patients with an occluded left anterior descending coronary artery. J Am Coll Cardiol 1996; 28:455-459.
21. Le Feuvre C, Baubion N, Aubry N, Metzger JP, de Vernejoul P, Vacheron A. Assessment of reversible dyssynergic segments after acute myocardial infarction: Dobutamine echocardiography versus thallium-201 single photon emission computed tomography. Am Heart J 1996; 131:668-675.
22. Picano E, Ostojic M, Varga A, et al. Combined low dose dipyridamole-dobutamine stress echocardiography to identify myocardial viability.J Am Coll Cardiol 1996; 27:1422-1428.
23. hiina A, Tajik AJ, Smith AC, Lengyel M, Seward JB. Prognostic significance of regional wall motion abnormality in patients with prior myocardial infarction: a prospective corelative study of two-dimensional echocardiography and angiography. Mayo Clin Proc 1986; 61:254-262.
24. Pagley PR, Beller GA, Watson DD, et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997; 96:793-800.
25. 201T1 uptake and comparative prediction of recovery of function. Circulation 1997; 95:626-635.